Culture and characterization of mesenchymal stem cells from human gingival tissue

Journal of Periodontology

Volumn 81, Issue 6, 2010, Pages 917-925

  Mitrano, Tomas I ^a   Grob, Melisa S ^a   Carrion, Flavio ^b   Nova Lamperti, Estefania ^b   Luz, Patricia A ^b   Fierro, Francisca S ^a,b   Quintero, Antonio ^b   Chaparro, Alejandra ^b   Sanz, Antonio ^b  

^a UNIVERSIDAD DE LOS ANDES   (Chile)

^b UNIVERSIDAD DE LOS ANDES   (Colombia)

Author keywords

Connective tissue cells; Fibroblasts; Gingiva; Immunomodulation; Mesenchymal stem cells

Indexed keywords

ADIPOGENESIS; ADULT STEM CELL; ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CELL DIFFERENTIATION; CHONDROGENESIS; CONNECTIVE TISSUE CELL; CYTOLOGY; FLOW CYTOMETRY; GINGIVA; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYMAL STEM CELL; METHODOLOGY; MONONUCLEAR CELL; PHYSIOLOGY; TISSUE ENGINEERING;

ADIPOGENESIS; ADULT STEM CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROGENESIS; CONNECTIVE TISSUE CELLS; FLOW CYTOMETRY; GINGIVA; HUMANS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSION; LEUKOCYTES, MONONUCLEAR; MESENCHYMAL STEM CELLS; OSTEOGENESIS; TISSUE ENGINEERING;

EID: 77953247307     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2010.090566     Document Type: Article

References (49)

1. Slavkin HC, Bartold PM. Challenges and potential in tissue engineering. Periodontol 2000 2006;41:9-15.
2. Albandar JM. Epidemiology and risk factors of periodontal diseases. Dent Clin North Am 2005;49:517-532, v-vi.
3. American Academy of Periodontology. Epidemiology of periodontal diseases (position paper). J Periodontol 2005;76:1406-1419.
4. Bartold PM, Shi S, Gronthos S. Stemcells and periodontal regeneration. Periodontol 2000 2006;40:164-172.
5. Kao RT, Murakami S, Beirne OR. The use of biologic mediators and tissue engineering in dentistry. Periodontol 2000 2009;50:127-153.
6. Kaihara S, Vacanti JP. Tissue engineering: Toward new solutions for transplantation and reconstructive surgery. Arch Surg 1999;134:1184-1188.
7. Pountos I, Corscadden D, Emery P, Giannoudis PV. Mesenchymal stem cell tissue engineering: Techniques for isolation, expansion and application. Injury 2007;38(Suppl. 4) : S23-S33.
8. Stephens P, Genever P. Non-epithelial oral mucosal progenitor cell populations. Oral Dis 2007;13:1-10.
9. Gronthos S, Akintoye SO, Wang CY, Shi S. Bone marrow stromal stem cells for tissue engineering. Periodontol 2000 2006;41:188-195.
10. Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 1966;16:381-390.
11. Krause DS, Theise ND, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone marrowderived stem cell. Cell 2001;105:369-377.
12. Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 2001;98:10344-10349.
13. Cesselli D, Beltrami AP, Rigo S, et al. Multipotent progenitor cells are present in human peripheral blood. Circ Res 2009;104:1225-1234.
14. Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: Regulation of niche, self-renewal and differentiation. Arthritis Res Ther 2007;9:204-214.
15. Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: Characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 2004;8:301-316.
16. Tuan RS, Boland G, Tuli R. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 2003;5:32-45.
17. Noth U, Osyczka AM, Tuli R, Hickok NJ, Danielson KG, Tuan RS. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 2002;20:1060-1069.
18. Sudo K, Kanno M, Miharada K, et al. Mesenchymal progenitors able to differentiate into osteogenic, chondrogenic, and/or adipogenic cells in-vitro are present in most primary fibroblast-like cell populations. Stem Cells 2007;25:1610-1617.
19. Dreyfus PA, Chretien F, Chazaud B, et al. Adult bone marrow-derived stem cells in muscle connective tissue and satellite cell niches. Am J Pathol 2004;164:773-779.
20. Toma JG, McKenzie IA, Bagli D, Miller FD. Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells 2005;23:727-737.
21. Seo BM, Miura M, Gronthos S, et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 2004;364:149-155.
22. Ohta S, Yamada S, Matuzaka K, Inoue T. The behavior of stem cells and progenitor cells in the periodontal ligament during wound healing as observed using immunohistochemical methods. J Periodontal Res 2008;43:595-603.
23. Kramer PR, Nares S, Kramer SF, Grogan D, Kaiser M. Mesenchymal stem cells acquire characteristics of cells in the periodontal ligament in-vitro. J Dent Res 2004;83:27-34.
24. Zhou Y, Hutmacher DW, Sae-Lim V, Zhou Z, Woodruff M, Lim TM. Osteogenic and adipogenic induction potential of human periodontal cells. J Periodontol 2008;79:525-534.
25. Suchanek J, Soukup T, Visek B, Ivancakova R, Kucerova L, Mokry J. Dental pulp stem cells and their characterization. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2009;153:31-35.
26. Morsczeck C, Götz W, Schierholz J, et al. Isolation of precursor cells (PCs) from human dental follicle of wisdom teeth. Matrix Biol 2005;24:155-165.
27. Park BW, Hah YS, Choi MJ, et al. In-vitro osteogenic differentiation of cultured human dental papilla-derived cells. J Oral Maxillofac Surg 2009;67:507-514.
28. Young HE, Steele TA, Bray RA, et al. Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 2001;264:51-62.
29. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all postnatal organs and tissues. J Cell Sci 2006;119:2204-2213.
30. Young HE, Mancini ML, Wright RP, et al. Mesenchymal stem cells reside within the connective tissues of many organs. Dev Dyn 1995;202:137-144.
31. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317.
32. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007;25:2739-2749.
33. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008;8:726-736.
34. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276:71-74.
35. Ishii M, Koike C, Igarashi A, et al. Molecular markers distinguish bone marrow mesenchymal stem cells from fibroblasts. Biochem Biophys Res Commun 2005;332:297-303.
36. Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99:3838-3843.
37. Krampera M, Glennie S, Dyson J, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003;101:3722-3729.
38. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in-vitro and prolong skin graft survival in-vivo. Exp Hematol 2002;30:42-48.
39. Pierdomenico L, Bonsi L, Calvitti M, et al. Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp. Transplantation 2005;80:836-842.
40. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
41. Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005;105:2821-2827.
42. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815-1822.
43. Beyth S, Borovsky Z, Mevorach D, et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 2005;105:2214-2219.
44. Nauta AJ, Kruisselbrink AB, Lurvink E, Willemze R, Fibbe WE. Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocytederived dendritic cells. J Immunol 2006;177:2080-2087.
45. Wada N, Menicanin D, Shi S, Bartold PM, Gronthos S. Immunomodulatory properties of human periodontal ligament stem cells. J Cell Physiol 2009;219:667-676.
46. Tyndall A, Walker UA, Cope A, et al. Immunomodulatory properties of mesenchymal stem cells: A review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res Ther 2007;9:301-311.
47. Lekic PC, Nayak BN, Al-Sanea R, Tenenbaum H, Ganss B, Mcculloch C. Cell transplantation in wounded mixed connective tissues. Anat Rec A Discov Mol Cell Evol Biol 2005;287:1256-1263.
48. McGuire MK, Scheyer ET. A randomized, doubleblind, placebo-controlled study to determine the safety and efficacy of cultured and expanded autologous fibroblast injection for the treatment of interdental papillary insufficiency associated with the papilla priming procedure. J Periodontol 2007;78:4-17.
49. McGuire MK, Nunn ME. Evaluation of the safety and efficacy of periodontal applications of a living tissueengineered human fibroblast-derived dermal substitute. I. Comparison to the gingival autograft: A randomized controlled pilot study. J Periodontol 2005;76:867-880.